These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 9689887)

  • 1. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy in a risk-benefit perspective.
    Daly E; Vessey MP; Barlow D; Gray A; McPherson K; Roche M
    Maturitas; 1996 Mar; 23(2):247-59. PubMed ID: 8735363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications for hormone replacement therapy].
    Birkhäuser MH
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness analysis of hormone replacement therapy in the menopause.
    Cheung AP; Wren BG
    Med J Aust; 1992 Mar; 156(5):312-6. PubMed ID: 1588862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and benefits of long-term treatment with estrogens.
    Mack TM; Ross RK
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1811-20. PubMed ID: 2692147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT.
    L'Hermite M
    Climacteric; 2013 Aug; 16 Suppl 1():44-53. PubMed ID: 23848491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
    Davis SR; Dinatale I; Rivera-Woll L; Davison S
    J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and estrogen-dependent cancers.
    Birkhäuser M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():99-114. PubMed ID: 7874193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The benefits and risks of hormonal replacement therapy--an update].
    Schmidt M; Kimmig R
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):166-73. PubMed ID: 17068401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated gains in life expectancy with use of postmenopausal estrogen therapy: a decision analysis.
    Zubialde JP; Lawler F; Clemenson N
    J Fam Pract; 1993 Mar; 36(3):271-80. PubMed ID: 8454973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.